Beaufort Securities reiterated their speculative buy rating on shares of Amryt Pharma PLC (LON:AMYT) in a research report report published on Wednesday morning.

Separately, Shore Capital restated a house stock rating on shares of Amryt Pharma PLC in a research report on Thursday, June 9th.

Shares of Amryt Pharma PLC (LON:AMYT) opened at 19.25 on Wednesday. The stock’s market capitalization is GBX 40.11 million. The firm’s 50-day moving average price is GBX 18.84 and its 200 day moving average price is GBX 19.06. Amryt Pharma PLC has a 52 week low of GBX 14.00 and a 52 week high of GBX 31.20.

Receive News & Ratings for Amryt Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.